Home
>
National Drug Code (NDC)
>
ADCIRCA
ADCIRCA - 66302-467-61 - (Tadalafil)
Drug Information of ADCIRCA
| Product NDC: | 66302-467 |
| Proprietary Name: | ADCIRCA |
| Non Proprietary Name: | Tadalafil |
| Active Ingredient(s): | 20 mg/1 & nbsp; Tadalafil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ADCIRCA
| Product NDC: | 66302-467 |
| Labeler Name: | United Therapeutics Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022332 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090522 |
Package Information of ADCIRCA
| Package NDC: | 66302-467-61 |
| Package Description: | 14 TABLET in 1 BOTTLE (66302-467-61) |
NDC Information of ADCIRCA
| NDC Code | 66302-467-61 |
| Proprietary Name | ADCIRCA |
| Package Description | 14 TABLET in 1 BOTTLE (66302-467-61) |
| Product NDC | 66302-467 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tadalafil |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090522 |
| Marketing Category Name | NDA |
| Labeler Name | United Therapeutics Corporation |
| Substance Name | TADALAFIL |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
